US2936024056 - ENSC (XNAS)
Ensysce Biosciences, Inc. - Common Stock Aktie
0,33 USD
Aktuelle Kurse von Ensysce Biosciences, Inc. - Common Stock
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung | Tagesveränderung % |
---|---|---|---|---|---|---|
NASDAQ |
ENSC
|
USD
|
20.09.2024 01:32
|
0,33 USD
| 0,34 USD | -1,46 % |
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
0,00 % | 1,26 % | -15,75 % | -36,24 % | -60,23 % | -79,87 % | -99,99 % |
Firmenprofil zu Ensysce Biosciences, Inc. - Common Stock Aktie
Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abuse Resistance platform, an over-dose protection opioid prodrug technology. The company is developing PF614, a TAAP prodrug candidate of oxycodone, which is in Phase II clinical trial for the treatment of acute or chronic pain; and PF614-MPAR, a combination product of PF614 and nafamostat that is in Phase I clinical trial for overdose protection against excessive oral ingestion, as well as an oral and inhalation drug product of nafamostat for use against coronaviral infections and other pulmonary diseases, such as cystic fibrosis. It is also developing PF329, an extended-release prodrug of hydromorphone that is similar to PF614; PF8001 and PF8026 are extended and immediate-release prodrugs of amphetamine for ADHD medication abuse; and PF26810, an extended-release prodrug of methadone for opioid use disorder. The company is based in La Jolla, California.
Unternehmensdaten zur Ensysce Biosciences, Inc. - Common Stock Aktie
Name Ensysce Biosciences, Inc. - Common Stock
Firma Ensysce Biosciences, Inc.
Symbol ENSC
Website https://www.ensysce.com
Heimatbörse
NASDAQ
ISIN US2936024056
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Dr. D. Lynn Kirkpatrick Ph.D.
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,0 T
Adresse 7946 Ivanhoe Avenue, 92037 La Jolla
IPO Datum 2018-03-14
Aktien Kennungs-Wechsel
Datum | Von | Zu |
---|---|---|
16.09.2018 | LACQU | ENSC |
Ticker Symbole
Name | Symbol |
---|---|
NASDAQ | ENSC |
Weitere Aktien
Investoren die Ensysce Biosciences, Inc. - Common Stock halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024